Teflaro

Forest Laboratories, Inc

Revision date : 2013-06-25

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07 GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2013-06-25

Product name

Teflaro

Product Synonyms

Ceftaroline, Ceftaroline Fosamil, PPI-0903, TAK-599, or Ceftaroline Acetate

Chemical name

N-phosphonoamino

CAS No.

400827-55-6

1.2.1 Relevant identified uses

Bulk formulated pharmaceutical product/Formulated pharmaceutical product; used of the substance or

Emergency telephone

1-(800) 424-9300, 1-(703) 527-3887

Icons in SDS

GHS08

Company Information

company name

Forest Laboratories, Inc

e-mail address of the competent person responsible for the Safety Data Sheet

ehs@frx.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H317, H334

Hazard statements

Code

Statements

H317

May cause an allergic skin reaction

Section 2

2.1 Classification of the substance or mixture

The classification and labelling listed below is for bulk Ceftaroline Fosamil for Injection (400 mg/vial and 600 mg/vial). Regulation (EC) Respiratory sensitizer - Category 1. Skin Sensitizer - Category 1. 1272/2008 [GHS] Directive 67/548/EEC Xn - R42/43 or 1999/45/EC SECTION 2 - HAZARDS IDENTIFICATION …continued

Signal word

Danger Danger SECTION 2 - HAZARDS IDENTIFICATION …continued US Hazard overview Contains ceftaroline fosamil- a cephalosporin antibiotic. May cause allergic respiratory/ skin reaction. Note This product/mixture is classified as dangerous/hazardous according to directive 1999/45/EC, Regulation EC No 1272/2008 (EU CLP) and applicable US regulations. The GHS classifications are based on Regulation (EC) 1272/2008. The EU symbol/indicator of danger, R Phrases and Safety Advice are based on Directive 1999/45/EC.

CLP CLASSIFICATION

H317 - May cause allergic skin reaction. H334 - May cause allergy or asthma

Hazard statements

symptoms or breathing difficulties if inhaled. CLP/GHS P261 - Avoid breathing dust. P272 - Contaminated work clothing should not be

Precautionary statements

allowed out of the workplace. P280 - Wear protective gloves/eye protection/face protection. P285 - In case of inadequate ventilation wear respiratory protection. P302 + P352 - If on skin: Wash with plenty of soap and water. P304 + P341 - IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. P363 - Wash contaminated clothing before reuse. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations. EU symbol/indication of danger Xn - Harmful Risk (R) Phrase(s) R42/43 - May cause sensitization by inhalation and skin contact. S22 - Do not breathe dust. S24 - Avoid contact with skin. S36/37 - Wear suitable protective clothing and gloves.

2.3 Other hazards

Ceftaroline fosamil for Injection is being used to treat certain microbial infections. It contains ceftaroline fosamil, a pro-drug of the cephalosporin antibiotic ceftaroline. In clinical trials, diarrhea, nausea, and skin rash were the most frequently reported adverse reactions. Cephalosporins, as a class, are known occupational sensitizers and can cause potentially severe sensitization/hypersensitivity reactions. Hypersensitivity reactions including anaphylaxis, bronchospasms, urticaria and pruritis have been reported in no more than 5% of patients receiving a cephalosporin. In patients with a known hypersensitivity to this class of compounds, cross-hypersensitivity can occur in up to 10% of patients.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.